These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34238101)

  • 1. Addiction treatment in the postpartum period: an opportunity for evidence-based personalized medicine.
    Martin CE; Parlier-Ahmad AB
    Int Rev Psychiatry; 2021 Sep; 33(6):579-590. PubMed ID: 34238101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding Medical Education to Include Substance Use Disorders During Pregnancy and Postpartum: Preliminary Effectiveness of a Pilot Curriculum for Medical Students.
    Martin CE; Martinez Telleria M; Hostetter K; Thumma L; Edwards C; Thakkar B
    J Addict Med; 2024 Mar-Apr 01; 18(2):191-193. PubMed ID: 38205928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance Use Disorder-Related Deaths and Maternal Mortality in New Mexico, 2015-2019.
    Fuchs JR; Schiff MA; Coronado E
    Matern Child Health J; 2023 Dec; 27(Suppl 1):23-33. PubMed ID: 37306823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Person-centered hospital discharge data: Essential existing infrastructure to enhance public health surveillance of maternal substance use disorders in the midst of a national maternal overdose crisis.
    D'Souza RR; Cooper HL; Chang HH; Rogers E; Wien S; Blake SC; Kramer MR
    Ann Epidemiol; 2024 Jun; 94():64-71. PubMed ID: 38677568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low barrier perinatal psychiatric care for patients with substance use disorder: meeting patients across the perinatal continuum where they are.
    Raffi ER; Gray J; Conteh N; Kane M; Cohen LS; Schiff DM
    Int Rev Psychiatry; 2021 Sep; 33(6):543-552. PubMed ID: 34406106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons Learned Serving Pregnant, Postpartum, and Parenting People with Substance Use Disorders in Massachusetts: The Moms Do Care Program.
    Sternberger L; Sorensen-Alawad A; Prescott T; Sakai H; Brown K; Finkelstein N; Salomon A; Schiff DM
    Matern Child Health J; 2023 Dec; 27(Suppl 1):67-74. PubMed ID: 37792152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
    Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
    Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outpatient treatment program.
    Sadicario JS; Parlier-Ahmad AB; Brechbiel JK; Islam LZ; Martin CE
    J Subst Abuse Treat; 2021 Mar; 122():108200. PubMed ID: 33250270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period.
    Smid MC; Terplan M
    Obstet Gynecol; 2022 Feb; 139(2):317-337. PubMed ID: 34991147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postpartum Treatment for Substance Use Disorder Among Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Substance Exposure.
    Faherty LJ; Heins S; Kranz AM; Stein BD
    Womens Health Rep (New Rochelle); 2021; 2(1):163-172. PubMed ID: 34235503
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized controlled trial of a gender-focused addiction model versus 12-step facilitation for women veterans.
    Najavits LM; Enggasser J; Brief D; Federman E
    Am J Addict; 2018 Apr; 27(3):210-216. PubMed ID: 29596724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to Support Engagement in Addiction Care Postpartum: Principles and Pitfalls.
    Mazel S; Alexander K; Cioffi C; Terplan M
    Subst Abuse Rehabil; 2023; 14():49-59. PubMed ID: 37424702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders.
    Tsai J; Gu X
    Addict Sci Clin Pract; 2019 Mar; 14(1):9. PubMed ID: 30836991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal Deaths From Suicide and Overdose in Colorado, 2004-2012.
    Metz TD; Rovner P; Hoffman MC; Allshouse AA; Beckwith KM; Binswanger IA
    Obstet Gynecol; 2016 Dec; 128(6):1233-1240. PubMed ID: 27824771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023).
    Harris M; Schiff DM; Saia K; Muftu S; Standish KR; Wachman EM
    Breastfeed Med; 2023 Oct; 18(10):715-733. PubMed ID: 37856658
    [No Abstract]   [Full Text] [Related]  

  • 17. Focusing on the Opioid System for Addiction Biomarker Discovery.
    Belzeaux R; Lalanne L; Kieffer BL; Lutz PE
    Trends Mol Med; 2018 Feb; 24(2):206-220. PubMed ID: 29396147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal Care Outcomes in Women with Substance Use Disorders: A Retrospective Cohort Study.
    Lennox R; Patel T; Marmel A; Shaw E
    J Obstet Gynaecol Can; 2021 Jul; 43(7):850-855. PubMed ID: 33301956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of substance use disorder among pregnant women in three state Medicaid programs from 2013 to 2016.
    Lynch V; Clemans-Cope L; Howell E; Hill I
    J Subst Abuse Treat; 2021 May; 124():108265. PubMed ID: 33771273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Sex-Specific Reproductive and Sexual Health Needs between Addiction Medicine and Primary Care Treatment Settings.
    Martin CE; Parlier-Ahmad AB; Beck L; Jain V; Terplan M
    Subst Use Misuse; 2022; 57(8):1229-1236. PubMed ID: 35607761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.